The United States is currently racing against time as the states try to vaccinate as many Americans as possible before the new variants begin to take over the country. Now, a very exciting new development this weekend will make this task easier: the third COVID-19 vaccine produced by Johnson & Johnson has been approved for emergency use in the United States, not only can it be 100% effective against hospitalization and Death, but it can also be injected once, which may double the process of immunizing the herd by vaccinating 70% to 85% of the population that we dream of progress. So, when can this new lens be used? Experts say it is earlier than you think. Read on to find out when the Johnson & Johnson vaccine may be on a site near you, and for more information on the latest vaccine guidelines, please see Dr. Fauci Just Just Do not take this drug for COVID vaccine.
The US Centers for Disease Control and Prevention (CDC) advisory group voted unanimously on Sunday to recommend that Johnson & Johnson vaccine be widely used among Americans over 18 years of age. Thereafter, the first delivery of Johnson & Johnson vaccine may arrive as early as Tuesday.
In the interview on Monday present day, CEO of Johnson & Johnson Alex Gorsky He said: “In the next 24 to 28 hours, Americans should begin to receive weapon shots. As we said, they were actually launched with trucks.” And, if you need to learn more about vaccines For news, please check “Pfizer Vaccine” (if you have this common situation, the effect may be poor).
The initial delivery volume was 4 million doses. Johnson & Johnson plans to ship more than 20 million doses of vaccines by the end of March and 100 million doses of vaccines by June. This is Gorsky’s commitment to the United States in his speech. present day In the interview, Johnson & Johnson hopes to “reach 1 billion by the end of 2021” and “we will work hard to ensure that we comply with all these commitments.” For more regular COVID updates sent directly to your inbox, please sign up for our daily news.
In addition to requiring only one injection instead of two injections, the Johnson & Johnson vaccine differs from Pfizer and Moderna’s injection vaccines in that it does not need to be frozen to maintain its efficacy, which should make it easier to transport across the country. Although federal officials emphasized that all three vaccines should be supplied equally across the country, the need for special storage and transportation facilities will make Johnson & Johnson’s vials easier to transport to hard-to-reach areas and communities.
Officials know that due to various reasons, the current vaccination rate in minority communities is lagging behind. Reuters quoted a senior White House official as saying: “Although we know that the data is incomplete, we do see these early phenomena, indicating that the vaccination rate of black and brown Americans is much lower than that of the general population.”
One attempt to solve this problem is to open up to 400 community vaccination centers and mobile vaccination units in populated areas. There is no need to freeze or to intensify the injection. It is hoped that the new vaccine from Johnson & Johnson will help quickly close this gap and protect more Americans as soon as possible. For more news about this new vaccine, check out Johnson & Johnson’s vaccine is 100% effective in this area.
Some people discuss that Johnson & Johnson is a vaccine for the “weak” because it has an effective rate of 72% against symptomatic COVID in the United States, while the protection rate of Moderna and Pfizer is about 95%. But Gausky explained how these numbers don’t tell the whole story.He said: “The really important thing to remember about this vaccine is that when we conduct clinical trials from October 2020 to January 2021, this is the period when the incidence of the virus is really at its peak.” present day.
Gorski said that clinical trials of Johnson & Johnson vaccines are conducted globally, with 40% of patients in Latin America and 15% in South Africa. In Brazil and South Africa, the two vaccines account for an increasing proportion. “When you look at the number of vaccines, the most important thing is that it can work against serious diseases 85% of the time, and even for these new and indeed challenging variants, it can keep all patients away In the hospital, there will be no death,” Gausky said. At the same time, the Moderna and Pfizer vaccines have not been tested against variants until recently, which is why those pharmaceutical companies are working hard to intensify injections to protect them from variants. For more information about future COVID vaccines, check out the CEO of Pfizer, saying that this is how you often need a COVID vaccine.